IMA logo

ImageneBio, Inc. Stock Price

NasdaqCM:IMA Community·US$68.5m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

IMA Share Price Performance

US$6.43
-9.94 (-60.72%)
US$6.43
-9.94 (-60.72%)
Price US$6.43

IMA Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet with slight risk.

4 Risks
0 Rewards

ImageneBio, Inc. Key Details

US$800.0k

Revenue

US$0

Cost of Revenue

US$800.0k

Gross Profit

US$54.2m

Other Expenses

-US$53.4m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
-5.01
100.00%
-6,669.75%
0%
View Full Analysis

About IMA

Founded
n/a
Employees
9
CEO
Kristin Yarema
WebsiteView website
www.inmagenebio.com

ImageneBio, Inc., a clinical-stage biotechnology company, develops therapeutics for immunological and inflammatory diseases. The company was formerly known as Ikena Oncology, Inc. and changed its name to ImageneBio, Inc. in July 2025. ImageneBio, Inc. is headquartered in San Diego, California.

Recent IMA News & Updates

Recent updates

No updates